Michael Foley is a research fellow at Imperial College London, an interventional cardiology fellow and a clinical trialist. He has an interest in placebo-controlled trials of cardiac interventions. Most recently he was first author of the ORBITA-COSMIC trial, a randomised, placebo-controlled trial of the coronary sinus reducer in refractory angina.
